Mount Kisco, NY, United States of America

Joel C Reinhardt


 

Average Co-Inventor Count = 5.6

ph-index = 6

Forward Citations = 161(Granted Patents)


Company Filing History:


Years Active: 2011-2022

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations of Joel C Reinhardt in Osteoarthritis Treatment

Introduction

Joel C Reinhardt is a notable inventor based in Mount Kisco, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of osteoarthritis. With a total of 9 patents to his name, Reinhardt's work has the potential to improve the quality of life for many individuals suffering from this condition.

Latest Patents

One of Reinhardt's latest patents is a method of treating osteoarthritis with an antibody to nerve growth factor (NGF). This innovative approach involves administering a therapeutically effective amount of an anti-human NGF antibody or an antigen-binding fragment to a human subject in need. The method aims to prevent, ameliorate, or improve at least one symptom associated with osteoarthritis, showcasing Reinhardt's commitment to advancing medical treatments.

Career Highlights

Reinhardt is currently associated with Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its focus on developing innovative medicines. His work at Regeneron has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his inventions.

Collaborations

Some of Reinhardt's notable coworkers include Lynn Macdonald and Richard Torres. Their collective expertise contributes to the advancement of research and development in the pharmaceutical industry.

Conclusion

Joel C Reinhardt's contributions to the treatment of osteoarthritis through innovative methods highlight his role as a significant inventor in the medical field. His work continues to pave the way for new therapeutic options that can benefit countless patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…